Xencor | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
AbbVie USD 610M 19M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amgen USD 747M 29M 2024-12
Arrowhead Research USD 21.65M 7M 2024-12
AstraZeneca 429M 28M 2024-12
Biogen USD 60M 200K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Cytokinetics USD 22.59M 296K 2024-12
GlaxoSmithKline 173M 17M 2024-12
J&J USD 137M 56M 2024-12
MacroGenics USD 0 6K 2024-09
Merck USD 328M 2M 2024-12
Novartis USD 275M 11M 2024-12
Pfizer USD 739M 45M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Xencor -39359000 40.15M 2024-12



Xencor Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.